Michael S. O’Reilly

16.3k total citations · 5 hit papers
79 papers, 12.0k citations indexed

About

Michael S. O’Reilly is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael S. O’Reilly has authored 79 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 34 papers in Cancer Research and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael S. O’Reilly's work include Angiogenesis and VEGF in Cancer (31 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer, Hypoxia, and Metabolism (23 papers). Michael S. O’Reilly is often cited by papers focused on Angiogenesis and VEGF in Cancer (31 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer, Hypoxia, and Metabolism (23 papers). Michael S. O’Reilly collaborates with scholars based in United States, China and United Kingdom. Michael S. O’Reilly's co-authors include Judah Folkman, Lars Holmgren, Thomas Boehm, Judah Folkman, Yuen Shing, Bjørn R. Olsen, William S. Lane, George Vasios, Naomi Fukai and Evelyn Flynn and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael S. O’Reilly

78 papers receiving 11.7k citations

Hit Papers

Endostatin: An Endogenous... 1995 2026 2005 2015 1997 1995 1997 1996 2018 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
    1997 3.7k citations Michael S. O’Reilly, Thomas Boehm et al. Cell profile →
  2. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
    1995 1.5k citations Lars Holmgren, Michael S. O’Reilly et al. profile →
  3. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
    1997 1.4k citations Thomas Boehm, Judah Folkman et al. profile →
  4. Angiostatin induces and sustains dormancy of human primary tumors in mice
    1996 975 citations Michael S. O’Reilly, Lars Holmgren et al. profile →
  5. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer
    2018 214 citations Zhongxing Liao, Ritsuko Komaki et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael S. O’Reilly 7.5k 4.6k 3.4k 2.1k 1.6k 79 12.0k
Giampietro Gasparini 5.0k 0.7× 3.4k 0.7× 4.1k 1.2× 1.5k 0.7× 688 0.4× 170 9.8k
Russell Leek 7.3k 1.0× 4.5k 1.0× 5.1k 1.5× 1.3k 0.6× 583 0.4× 109 12.5k
Celina G. Kleer 9.2k 1.2× 5.8k 1.2× 7.9k 2.3× 1.9k 0.9× 611 0.4× 174 17.2k
F. Jänicke 3.1k 0.4× 6.2k 1.3× 5.5k 1.6× 1.6k 0.8× 1.2k 0.7× 183 11.3k
Robert Radinsky 4.5k 0.6× 2.2k 0.5× 6.3k 1.8× 2.5k 1.2× 456 0.3× 127 10.4k
Thomas Boehm 4.2k 0.6× 2.2k 0.5× 1.2k 0.4× 895 0.4× 1.1k 0.7× 87 7.4k
Francesco Pezzella 7.0k 0.9× 4.5k 1.0× 4.1k 1.2× 1.9k 0.9× 325 0.2× 159 12.1k
Robert L. Camp 6.2k 0.8× 2.4k 0.5× 5.7k 1.7× 2.3k 1.1× 658 0.4× 118 12.8k
Nils Brünner 4.0k 0.5× 5.0k 1.1× 4.1k 1.2× 917 0.4× 1.4k 0.9× 238 9.9k
Steven J. Isakoff 3.9k 0.5× 2.8k 0.6× 5.0k 1.5× 2.0k 0.9× 581 0.4× 176 9.3k

Countries citing papers authored by Michael S. O’Reilly

Since Specialization
Citations

This map shows the geographic impact of Michael S. O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. O’Reilly more than expected).

Fields of papers citing papers by Michael S. O’Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. O’Reilly. The network helps show where Michael S. O’Reilly may publish in the future.

Co-authorship network of co-authors of Michael S. O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. O’Reilly. A scholar is included among the top collaborators of Michael S. O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. O’Reilly. Michael S. O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Matthew S., Joe Y. Chang, Saumil Gandhi, et al.. (2024). Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. Cancers. 16(21). 3587–3587. 2 indexed citations
2.
3.
McGinnis, Gwendolyn J., Matthew S. Ning, P Nitsch, et al.. (2020). Rapid Detection of Asymptomatic Coronavirus Disease 2019 by Computed Tomography Image Guidance for Stereotactic Ablative Radiotherapy. Journal of Thoracic Oncology. 15(6). 1085–1087. 10 indexed citations
4.
Luo, Gang, David R. Haynor, Michael S. O’Reilly, et al.. (2020). DicomAnnotator: a Configurable Open-Source Software Program for Efficient DICOM Image Annotation. Journal of Digital Imaging. 33(6). 1514–1526. 5 indexed citations
5.
Sun, Bing, Eric D. Brooks, Ritsuko Komaki, et al.. (2017). Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial. Journal of Thoracic Oncology. 12(6). 983–992. 52 indexed citations
6.
Chang, Joe Y., Wencheng Zhang, Ritsuko Komaki, et al.. (2017). Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiotherapy and Oncology. 122(2). 274–280. 28 indexed citations
7.
Isobe, Takeshi, Amir Onn, Daniel Morgensztern, et al.. (2013). Evaluation of Novel Orthotopic Nude Mouse Models for Human Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(2). 140–146. 26 indexed citations
8.
Yin, Ming, Zhongxing Liao, Xianglin Yuan, et al.. (2012). Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non‐small cell lung cancer patients treated with definitive radiotherapy. Cancer Science. 103(5). 945–950. 26 indexed citations
9.
Gomez, Daniel R., Gregory W. Gladish, Wei Xiong, et al.. (2012). Prognostic Value of Positron Emission Tomography/Computed Tomography Findings in Limited-stage Small Cell Lung Cancer Before Chemoradiation Therapy. American Journal of Clinical Oncology. 37(1). 77–80. 13 indexed citations
10.
Skinner, Heath D., Matthew R. McCurdy, Steven H. Lin, et al.. (2012). Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncologica. 52(5). 1002–1009. 92 indexed citations
11.
Jacoby, Jörg J., Baruch Erez, Ryan Williams, et al.. (2010). Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice. Journal of Thoracic Oncology. 5(7). 940–949. 67 indexed citations
12.
Guan, Xiaoxiang, Ming Yin, Qingyi Wei, et al.. (2010). Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer. 10(1). 431–431. 26 indexed citations
13.
O’Reilly, Michael S.. (2007). Antiangiogenesis and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Targeting as Part of a Combined-Modality Approach to the Treatment of Cancer. International Journal of Radiation Oncology*Biology*Physics. 69(2). S64–S66. 19 indexed citations
14.
Marcus, Karen, Rosalyn M. Adam, Michael S. O’Reilly, et al.. (2005). Tumor cell‐associated neuropilin‐1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma. Neuropathology. 25(3). 178–187. 19 indexed citations
15.
Wu, Wenjuan, Takeshi Isobe, Satoshi Itasaka, et al.. (2004). ZD6474, a small molecule targeting VEGF and EGF receptor signaling, inhibits lung angiogenesis and metastasis and improves survival in an orthotopic model of non-small cell lung cancer. Cancer Research. 64. 1051–1051. 12 indexed citations
16.
Onn, Amir, Arlene M. Correa, Michael Z. Gilcrease, et al.. (2004). Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2- neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer. Clinical Cancer Research. 10(1). 136–143. 122 indexed citations
17.
Greene, Arin K., Stephen M. Wiener, Mark Puder, et al.. (2003). Endothelial-Directed Hepatic Regeneration After Partial Hepatectomy. Annals of Surgery. 237(4). 530–535. 96 indexed citations
18.
O’Reilly, Michael S., Dmitri Wiederschain, William G. Stetler‐Stevenson, Judah Folkman, & Marsha A. Moses. (1999). Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance. Journal of Biological Chemistry. 274(41). 29568–29571. 213 indexed citations
19.
O’Reilly, Michael S., Thomas Boehm, Yuen Shing, et al.. (1997). Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth. Cell. 88(2). 277–285. 3657 indexed citations breakdown →
20.
Cao, Yihai, Donald J. Davidson, Johann Schaller, et al.. (1996). Kringle Domains of Human Angiostatin. Journal of Biological Chemistry. 271(46). 29461–29467. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giampietro Gasparini Breakdown of academic impact, for papers by Russell Leek Breakdown of academic impact, for papers by Celina G. Kleer Breakdown of academic impact, for papers by F. Jänicke Breakdown of academic impact, for papers by Robert Radinsky Breakdown of academic impact, for papers by Thomas Boehm Breakdown of academic impact, for papers by Francesco Pezzella Breakdown of academic impact, for papers by Robert L. Camp Breakdown of academic impact, for papers by Nils Brünner Breakdown of academic impact, for papers by Steven J. Isakoff
Rankless by CCL
2026